Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
cancer
2
×
startups
abbvie
adalimumab (humira)
aducanumab
aduro biotech
affordable care act
alez azar
alzheimer's disease
antibiotics
axial spondyloarthritis
bausch health
bio
biogen
biotech
boston blog main
boston top stories
boston university
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
california
cancer immunotherapy
car-t immunotherapy
cell therapy
clinical trials
cluster headache
crispr
deals
detroit blog main
detroit top stories
diagnostics
digital health
dihydroergotamine
dimitry nuyten
disease
drug prices
eddingpharm
eli lilly
elizabeth holmes
What
remains
2
×
according
approval
attacks
bio
biogen’s
biopharmaceutical
bioscience
cancer
companies
convo
counterpoint
diagnosis
died
disease
drug
earlier
failures
globally
health
history
human
initial
littered
march
medical
million
nash
new
news
organization
people
physiology
price
progress
received
road
roundup
scored
strategy
Language
Current search:
remains
×
cancer
×
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@techcrunch.com
6 years ago
Tradewind Bioscience attacks the physiology of tumors to treat cancer
